Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families

被引:0
|
作者
Liozon, E. [1 ]
Ouattara, B. [1 ]
Rhaiem, K. [1 ]
Ly, K. [1 ]
Bezanahary, H. [1 ]
Loustaud, V. [1 ]
Letellier, P. [3 ]
Drouet, M. [2 ]
Vidal, E. [1 ]
机构
[1] Dupuytren Univ Hosp, Dept Internal Med, Limoges, France
[2] Dupuytren Univ Hosp, Immunol & Immunogenet Labs, Limoges, France
[3] Univ Hosp, Dept Internal Med & Clin Immunol, Caen, France
关键词
giant cell arteritis; polymyalgia rheumatica; familial aggregation; genetic factors; environmental factors; POLYMERASE-CHAIN-REACTION; VARICELLA-ZOSTER-VIRUS; TEMPORAL ARTERITIS; CHLAMYDIA-PNEUMONIAE; PARVOVIRUS B19; NORTHWESTERN SPAIN; BIOPSY SPECIMENS; HORTONS DISEASE; OLMSTED COUNTY; MARRIED COUPLE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To review personal and published observations of giant cell (temporal) arteritis (GCA) or polymyalgia rheumatica (PMR) with familial or conjugal aggregation and emphasise on epidemiological, clinical and genetic features of such cases. Methods. We pooled data obtained front all cases of GCA or PMR with familial aggregation recruited in the department since 1976 and those from reports of familial or conjugal GCA or PMR published in the French-English literature since 1970. Results. During the study period, we diagnosed 460 patients (128 with isolated PMR, 22 7 with isolated GCA, 105 with PMR/CGA). No conjugal couples were observed it? the whole series. No familial cases were identified among PMR patients, whereas the prevalence of familial GCA was I in 83 (1 in 250 to 500 expected by chance), as we identified 4 patients (brother-brother, sister with history of affected sister, and daughter with prior), affected mother). An additional pair of sisters with TA, recruited several months after diagnosis, is also presented. Pooling data from 85 patients (74 with GCA) including our patients, representing 32 families and 8 conjugal pairs, enabled its to draw the following observations: 1) partial or full agreement in the clinical picture (GCA, PMR, or GCA/PMR) was observed in 96% of the siblings pairs, suggesting a common pathogenic mechanism; 2)five kindred were described in whom at least three members were affected; 3) the lag between manifested diseases in familial or conjugal pairs averaged 5.7 years, with synchronous or close disease occurrence in only 26% of the pairs; 4) 18 of 32 assessed patients (56%) carried the DR4 antigen. Conclusion. Our survey on familial aggregation of GCA and PMR accumulated data pointing to a genetic predisposition. However, environmental contagious factors could have trigger synchronous disease onset in lip to one-fourth of the cases.
引用
收藏
页码:S89 / S94
页数:6
相关论文
共 50 条
  • [1] Familial giant cell arteritis and polymyalgia rheumatica: Aggregation in 2 families
    Fietta, P
    Manganelli, P
    Zanetti, A
    Neri, TM
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (07) : 1551 - 1555
  • [2] Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
    Marcin Milchert
    Marek Brzosko
    Rheumatology International, 2020, 40 : 2071 - 2075
  • [3] Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
    Milchert, Marcin
    Brzosko, Marek
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (12) : 2071 - 2075
  • [4] Polymyalgia Rheumatica and Giant Cell Arteritis: A Case Report and Review of Literature
    Ulusoy, Hasan
    Sarica, Nebahat
    Arslan, Sule
    TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2009, 55 (01): : 45 - 49
  • [5] Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review
    Sharma, Ankita
    Mohammad, Aladdin J.
    Turesson, Carl
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 1040 - 1048
  • [6] Familial aggregation of polymyalgia rheumatica and giant cell arteritis:: Genetic and T cell repertoire analysis
    Bartolome, MJ
    Martínez-Taboda, VM
    Lopez-Hoyos, M
    Blanco, R
    Rodriguez-Valverde, V
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (03) : 259 - 264
  • [7] Managing of giant cell arteritis and polymyalgia rheumatica
    Gonzalez-Gay, Miguel A.
    Castaneda, Santos
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (11): : 1133 - 1144
  • [8] Giant Cell Arteritis and Polymyalgia Rheumatica: an Update
    Gonzalez-Gay, Miguel A.
    Pina, Trinitario
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (02)
  • [9] Polymyalgia rheumatica and giant cell arteritis
    Patel, Martyn
    Forsyth, Duncan R.
    JOURNAL OF CLINICAL GERONTOLOGY & GERIATRICS, 2011, 2 (01) : 7 - 12
  • [10] Current understanding and management of giant cell arteritis and polymyalgia rheumatica
    Ghosh, Parasar
    Borg, Frances A.
    Dasgupta, Bhaskar
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (06) : 913 - 928